Headlines

Edwards Lifesciences (EW) Q3 2026 (USD): Adj. EPS 0.80 (exp. 0.74), Revenue 1.72bln (exp. 1.68bln)

Newsquawk Staff ·

  • Sees Q4 Adj. EPS USD 0.61-0.69 (exp. 0.71)
  • Sees Q4 rev. 1.67bln-1.75bln (exp. 1.70bln)

Related headlines